Literature DB >> 14670756

Liquid chromatographic method for simultaneous determination of mycophenolic acid and its phenol- and acylglucuronide metabolites in plasma.

GholamAli Khoschsorur1, Wolfgang Erwa.   

Abstract

A simple, sensitive and reproducible HPLC method is presented for the simultaneous determination of mycophenolic acid (MPA) and its metabolites phenolic MPA-glucuronide (MPAG) and acyl glucuronide (AcMPAG) in human plasma. Sample purification requires protein precipitation with 0.1 M phosphoric acid/acetonitrile in the presence of Epilan D as an internal standard (IS). Separation was performed by reversed-phase HPLC, using a Zorbax SB-C18 column, 32% acetonitrile and a 40 mM phosphoric acid buffer at pH 3.0 as mobile phase; column temperature was 50 degrees C, flow rate 1.4 ml/min, and measurement by UV detection was at 215 nm (run time 12 min). The method requires only 50 microl plasma. Detection limits were 0.1 microg/ml for MPA and AcMPAG, and 2.0 microg/ml for MPAG, respectively. Mean absolute recovery of all three analytes was >95%. This analytical method for the determination of MPA and its metabolites is a reliable and convenient procedure that meets the criteria for application in routine clinical drug monitoring and pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670756     DOI: 10.1016/j.jchromb.2003.10.074

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  A high-throughput U-HPLC-MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine.

Authors:  Jacek Klepacki; Jelena Klawitter; Jamie Bendrick-Peart; Bjorn Schniedewind; Svenja Heischmann; Touraj Shokati; Uwe Christians; Jost Klawitter
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-08-02       Impact factor: 3.205

Review 2.  Clinical mycophenolic acid monitoring in liver transplant recipients.

Authors:  Hao Chen; Bing Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  Pharmacokinetics, electrophysiological, and morphological effects of the intravitreal injection of mycophenolic acid in rabbits.

Authors:  Fabio Gasparin; Renata Genaro Aguiar; Gabriela Lourençon Ioshimoto; Armando Silva-Cunha; Silvia Ligório Fialho; André Mauricio Liber; Balázs Vince Nagy; Nestor Norio Oiwa; Marcelo Fernandes Costa; Christina Joselevitch; Dora Fix Ventura; Francisco Max Damico
Journal:  J Ocul Pharmacol Ther       Date:  2014-05-14       Impact factor: 2.671

4.  Validated Simple HPLC-UV Method for Mycophenolic Acid (MPA) Monitoring in Human Plasma. Internal Standardization: Is It Necessary?

Authors:  Paweł K Kunicki; Aleksandra Wróbel
Journal:  Molecules       Date:  2021-11-29       Impact factor: 4.411

5.  Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination-A Non-randomized, Controlled Pilot Study.

Authors:  Florina Regele; Andreas Heinzel; Karin Hu; Lukas Raab; Farsad Eskandary; Ingrid Faé; Sieglinde Zelzer; Georg A Böhmig; Gregor Bond; Gottfried Fischer; Rainer Oberbauer; Roman Reindl-Schwaighofer
Journal:  Front Med (Lausanne)       Date:  2022-06-10

6.  Vitreous pharmacokinetics and electroretinographic findings after intravitreal injection of acyclovir in rabbits.

Authors:  Francisco Max Damico; Mariana Ramos Scolari; Gabriela Lourençon Ioshimoto; Beatriz Sayuri Takahashi; Armando da Silva Cunha; Sílvia Ligório Fialho; Daniela Maria Bonci; Fabio Gasparin; Dora Fix Ventura
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.